Human Papillomavirus Vaccines. PMID: 34590141
Prophylactic HPV vaccination: past, present, and future. PMID: 26429676
Treatment with Radix Euphorbiae Ebracteolatae Significantly Decreases the Expression of E6 and L1, and Increases the Expression of p53 and Rb in HPV18-infected Human Foreskin Keratinocytes. PMID: 30813877
Can a single dose of human papillomavirus (HPV) vaccine prevent cervical cancer? Early findings from an Indian study. PMID: 29551226
Efficacy of the bivalent HPV vaccine against HPV 16/18-associated precancer: long-term follow-up results from the Costa Rica Vaccine Trial. PMID: 33271093
Phylogeny and Classification of Human Papillomavirus (HPV)16 and HPV18 Variants Based on E6 and L1 genes in Tunisian Women with Cervical Lesions. PMID: 30583341
Glutathione S-transferase L1 multiplex serology as a measure of cumulative infection with human papillomavirus. PMID: 24588945
Development and characterization of an HPV18 detection kit using two novel HPV18 type-specific monoclonal antibodies. PMID: 30115088
Worldwide genetic variations in high-risk human papillomaviruses capsid L1 gene and their impact on vaccine efficiency. PMID: 33636291
Immunotherapy Targeting HPV16/18 Generates Potent Immune Responses in HPV-Associated Head and Neck Cancer. PMID: 30242022
Study of infectious virus production from HPV18/16 capsid chimeras. PMID: 20598725
PD-L1 expressed from tumor cells promotes tumor growth and invasion in lung cancer via modulating TGF-β1/SMAD4 expression. PMID: 35373505
A ten-year study of immunogenicity and safety of the AS04-HPV-16/18 vaccine in adolescent girls aged 10-14 years. PMID: 31268383
A comparison of methylation levels in HPV18, HPV31 and HPV33 genomes reveals similar associations with cervical precancers. PMID: 24468012
Controlled Hybrid-Assembly of HPV16/18 L1 Bi VLPs in Vitro. PMID: 27998118
The Effect of Indian Fig Fruit Extract on Human Papilloma Virus containing Cervical Cancer Cells (HeLa) by Decreasing the HPV18 L1 Gene Load. PMID: 33773542
Human papillomavirus (HPV) L1 and L1-L2 virus-like particle-based multiplex assays for measurement of HPV virion antibodies. PMID: 22761294
Multivalent human papillomavirus l1 DNA vaccination utilizing electroporation. PMID: 23536912
HPV vaccine: Cervarix. PMID: 20132062
The Synthesis of Main Capsid Protein of Anogenital Type HPV6 L1 in Plant Expression System on the Basis of Tomato Fruits. PMID: 34189649
[Human papillomavirus vaccines]. PMID: 18187268
Genetic Variability in the E6, E7, and L1 Genes of Human Papillomavirus Types 16 and 18 among Women in Saudi Arabia. PMID: 36680149
Fifteen new nucleotide substitutions in variants of human papillomavirus 18 in Korea : Korean HPV18 variants and clinical manifestation. PMID: 32448303
A cyclin-binding motif in human papillomavirus type 18 (HPV18) E1^E4 is necessary for association with CDK-cyclin complexes and G2/M cell cycle arrest of keratinocytes, but is not required for differentiation-dependent viral genome amplification or L1 capsid protein expression. PMID: 21276999
Enhanced expression of soluble human papillomavirus L1 through coexpression of molecular chaperonin in Escherichia coli. PMID: 26732286
Identification of the mimotopes within the major capsid protein L1 of human papillomavirus types 18 and 45, using neutralizing monoclonal antibodies. PMID: 33493568
L1 Recombinant Proteins of HPV Tested for Antibody Forming Using Sera of HPV Quadrivalent Vaccine. PMID: 29984037
Aberrant DNA methylation in cervical carcinogenesis. PMID: 22943599
Sex differences in HPV immunity among adults without cancer. PMID: 30650013
HPV single-dose vaccination: Impact potential, evidence base and further evaluation. PMID: 29754700
The Prognostic Values of HPV Genotypes and Tumor PD-L1 Expression in Patients With HPV-associated Endocervical Adenocarcinoma. PMID: 35175967
Immunogenicity assessment of HPV16/18 vaccine using the glutathione S-transferase L1 multiplex serology assay. PMID: 25483632
Development of chimeric candidate vaccine against HPV18: a proof of concept. PMID: 25929429
Expression and purification of human papillomavirus 18 L1 virus-like particle from saccharomyces cerevisiae. PMID: 18365691
Prophylactic human papillomavirus vaccines. PMID: 16670757
The First Human Vulvar Intraepithelial Neoplasia Cell Line with Naturally Infected Episomal HPV18 Genome. PMID: 36146860
Characteristics of human papillomavirus infection among females and the genetic variations of HPV18 and HPV58 in Henan province, China. PMID: 36755053
A phase I study to evaluate a human papillomavirus (HPV) type 18 L1 VLP vaccine. PMID: 15297048
Methylation of the L1 gene and integration of human papillomavirus 16 and 18 in cervical carcinoma and premalignant lesions. PMID: 29434935
Liquid biopsy of HPV DNA in cervical cancer. PMID: 30913520
Epitope design of L1 protein for vaccine production against Human Papilloma Virus types 16 and 18. PMID: 28584449
Utility of human papillomavirus L1 capsid protein and HPV test as prognostic markers for cervical intraepithelial neoplasia 2+ in women with persistent ASCUS /LSIL cervical cytology. PMID: 31523171
Broad Cross-Protection Is Induced in Preclinical Models by a Human Papillomavirus Vaccine Composed of L1/L2 Chimeric Virus-Like Particles. PMID: 27147749
HPV types 16/18 L1 E6 and E7 proteins seropositivity and cervical cancer risk in HIV-positive and HIV-negative black South African women. PMID: 35351184
Integration sites of human papillomavirus 18 in esophageal cancer samples. PMID: 29731894
Methylation of the human papillomavirus-18 L1 gene: a biomarker of neoplastic progression? PMID: 16472835
The chromatin insulator CTCF regulates HPV18 transcript splicing and differentiation-dependent late gene expression. PMID: 34735550
HPV genotyping by L1 amplicon sequencing of archived invasive cervical cancer samples: a pilot study. PMID: 35945577
[The human papillomavirus vaccine: is it of value in dermatology?]. PMID: 22296714
Evolutionary dynamics of variant genomes of human papillomavirus types 18, 45, and 97. PMID: 19036820
The possible regions to design Human Papilloma Viruses vaccine in Iranian L1 protein. PMID: 32435064
Genetic diversity in L1 ORF of human papillomavirus in women with cervical cancer with and without human immunodeficiency virus in Botswana and Kenya. PMID: 35086475
Different DNA methylation pattern of HPV16, HPV18 and HPV51 genomes in asymptomatic HPV infection as compared to cervical neoplasia. PMID: 26119875
Comparative Evaluation of Human Papillomavirus Type 16 L1 Protein Expressed in Plasmid- and Baculovirus-Based Systems in Insect Cells. PMID: 32621447
Prospects for cervical cancer prevention by human papillomavirus vaccination. PMID: 17079437
A CRR2-Dependent sRNA Sequence Supports Papillomavirus Vaccine Expression in Tobacco Chloroplasts. PMID: 36984756
Correlation between viral load, multiplicity of infection, and persistence of HPV16 and HPV18 infection in a Dutch cohort of young women. PMID: 27522635
Genetic variability of human papillomavirus type 66 L1 gene among women presenting for cervical cancer screening in Chile. PMID: 31165237
Human papillomavirus type 16 E6, E7 and L1 and type 18 E7 proteins produced by recombinant baculoviruses. PMID: 8106603
[Progress and challenges on HPV vaccination]. PMID: 20218332
Intra-host sequence variability in human papillomavirus. PMID: 29723682
Chimeric L1-L2 virus-like particles as potential broad-spectrum human papillomavirus vaccines. PMID: 19640991
[Diseases caused by human papilloma viruses]. PMID: 21560109
Assessing human papillomavirus vaccine efficacy and safety. PMID: 18463363
Human Papillomavirus and Thyroid Eye Disease., PMID:40272832
[A fluorescence immunochromatography method for detection of human papillomavirus type 16 E6 and L1 proteins]., PMID:39584350
A Novel Association Between Human Papillomavirus and Thyroid Eye Disease., PMID:38746201
Differences in HPV-specific antibody Fc-effector functions following Gardasil® and Cervarix® vaccination., PMID:36922512
Serologic Response to Human Papillomavirus Genotypes Among Unvaccinated Women: Findings From the HITCH Cohort Study., PMID:36322543
RG2-VLP: a Vaccine Designed to Broadly Protect against Anogenital and Skin Human Papillomaviruses Causing Human Cancer., PMID:35703545
Designing of DNA Vaccine Based on a Secretory Form of Major Capsid Protein of Human Papillomavirus Type 18., PMID:34664812
The Synthesis of Main Capsid Protein of Anogenital Type HPV6 L1 in Plant Expression System on the Basis of Tomato Fruits., PMID:34189649
Worldwide genetic variations in high-risk human papillomaviruses capsid L1 gene and their impact on vaccine efficiency., PMID:33636291
Improvement of RG1-VLP vaccine performance in BALB/c mice by substitution of alhydrogel with the next generation polyphosphazene adjuvant PCEP., PMID:33573433
Identification of the mimotopes within the major capsid protein L1 of human papillomavirus types 18 and 45, using neutralizing monoclonal antibodies., PMID:33493568
Optimization of RG1-VLP vaccine performance in mice with novel TLR4 agonists., PMID:33309485
Phylogeny and In Silico Structure Analysis of Major Capsid Protein (L1) Human Papillomavirus 45 from Indonesian Isolates., PMID:32986347
Comprehensive Assessment of the Antigenic Impact of Human Papillomavirus Lineage Variation on Recognition by Neutralizing Monoclonal Antibodies Raised against Lineage A Major Capsid Proteins of Vaccine-Related Genotypes., PMID:32967963
Simultaneous quantification of major capsid protein of human papillomavirus 16 and human papillomavirus 18 in multivalent human papillomavirus vaccines by liquid chromatography-tandem mass spectrometry., PMID:32067760
Rational design of a triple-type human papillomavirus vaccine by compromising viral-type specificity., PMID:30560935
Epitope clustering analysis for vaccine-induced human antibodies in relationship to a panel of murine monoclonal antibodies against HPV16 viral capsid., PMID:30287156
Development and characterization of an HPV18 detection kit using two novel HPV18 type-specific monoclonal antibodies., PMID:30115088
L1 Recombinant Proteins of HPV Tested for Antibody Forming Using Sera of HPV Quadrivalent Vaccine., PMID:29984037
A Dual-Type L2 11-88 Peptide from HPV Types 16/18 Formulated in Montanide ISA 720 Induced Strong and Balanced Th1/Th2 Immune Responses, Associated with High Titers of Broad Spectrum Cross-Reactive Antibodies in Vaccinated Mice., PMID:29854852
Human papillomavirus 16L1-58L2 chimeric virus-like particles elicit durable neutralizing antibody responses against a broad-spectrum of human papillomavirus types., PMID:28968993
Immunization of mice by a multimeric L2-based linear epitope (17-36) from HPV type 16/18 induced cross reactive neutralizing antibodies., PMID:28855937
Characterization of an Escherichia coli-derived human papillomavirus type 16 and 18 bivalent vaccine., PMID:28736197
Development of a simple and quick immunochromatography method for detection of anti-HPV-16/-18 antibodies., PMID:28158224
The DE and FG loops of the HPV major capsid protein contribute to the epitopes of vaccine-induced cross-neutralising antibodies., PMID:28004837
Broad Cross-Protection Is Induced in Preclinical Models by a Human Papillomavirus Vaccine Composed of L1/L2 Chimeric Virus-Like Particles., PMID:27147749
Characterization of serum antibodies from women immunized with Gardasil: A study of HPV-18 infection of primary human keratinocytes., PMID:27113165
Observations on the expression of human papillomavirus major capsid protein in HeLa cells., PMID:26064080
Seroprevalence of 10 human papillomavirus types in the general rural population of Anyang, China: a cross-sectional study., PMID:25999521
Development of chimeric candidate vaccine against HPV18: a proof of concept., PMID:25929429
A chimeric 18L1-45RG1 virus-like particle vaccine cross-protects against oncogenic alpha-7 human papillomavirus types., PMID:25790098
HIV is an important risk factor for human papillomavirus types 16 and 18 seropositivity among sexually active men who have sex with men., PMID:25668644
Pre-clinical immunogenicity of human papillomavirus alpha-7 and alpha-9 major capsid proteins., PMID:25203446
Amino acid sequence diversity of the major human papillomavirus capsid protein: implications for current and next generation vaccines., PMID:23722024
Multivalent human papillomavirus l1 DNA vaccination utilizing electroporation., PMID:23536912
Detection of HPV E7 oncoviral protein in cervical lesions by a new antibody., PMID:22935825
Human papillomavirus (HPV) L1 and L1-L2 virus-like particle-based multiplex assays for measurement of HPV virion antibodies., PMID:22761294
Development of bead-based immunoassay to quantify neutralizing antibody for human papillomavirus 16 and 18., PMID:22669586
Comparison of the immune responses to the CIA06-adjuvanted human papillomavirus L1 VLP vaccine with those against the licensed HPV vaccine Cervarix™ in mice., PMID:22561312
Systemic and mucosal immune responses to sublingual or intramuscular human papilloma virus antigens in healthy female volunteers., PMID:22438987
Oral administration of HPV-16 L2 displayed on Lactobacillus casei induces systematic and mucosal cross-neutralizing effects in Balb/c mice., PMID:22426329
InterSCOPE study: Associations between esophageal squamous cell carcinoma and human papillomavirus serological markers., PMID:22228147
Capsomer vaccines protect mice from vaginal challenge with human papillomavirus., PMID:22069498
Expression of codon optimized major capsid protein (L1) of human papillomavirus type 16 and 18 in Pichia pastoris; purification and characterization of the virus-like particles., PMID:21803095
Genetic variability in the major capsid L1 protein of human papillomavirus type 16 (HPV-16) and 18 (HPV-18)., PMID:21729769
Cross-neutralization potential of native human papillomavirus N-terminal L2 epitopes., PMID:21346798
Papillomavirus capsid proteins mutually impact structure., PMID:21329956
The humoral response to Gardasil over four years as defined by total IgG and competitive Luminex immunoassay., PMID:21307649
Seroprevalence and determinants of eight high-risk human papillomavirus types in homosexual men, heterosexual men, and women: a population-based study in Amsterdam., PMID:20729796
Papillomavirus pseudovirions packaged with the L2 gene induce cross-neutralizing antibodies., PMID:20334659
For research use only. Not for human or drug use.
